Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-24

Clinical Trial Update: Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai

View source ↗

Summary

A clinical trial is recruiting to evaluate breast mapping and detection of suspicious breast lesions using a device called Feminai.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Feminai

Snippet

Sponsor: Feminai | Conditions: Breast Cancer Awareness | Status: RECRUITING